Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis

Details for Australian Patent Application No. 2002332014 (hide)

International Classifications

Event Publications

6 February 2003 Complete Application Filed

Priority application(s): 60/327,060 03.10.01 US; 10/261,198 30.09.02 US

26 June 2003 Application Open to Public Inspection

Published as AU-B-2002332014

16 November 2006 Application Accepted

Published as AU-B-2002332014

23 November 2006 Change of Name(s) of Applicant(s), Section 104

Signal Pharmaceuticals, Inc. The name of the applicant has been changed to Signal Pharmaceuticals, LLC. 2003

15 March 2007 Standard Patent Sealed

29 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.